Skip to Main Content
Contribute Try STAT+ Today

Part of the allure of software-based medical treatments is the possibility of reaching people in need at scale. And there’s no scale as compelling as absolutely everyone. 

Scotland’s National Health Service today announced that all adults in the country will have easy access to products from digital therapeutics developer Big Health. Roughly 5 million people will be eligible for access to Sleepio, the company’s product to treat insomnia with CBT, and Daylight, which is indicated for anxiety.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment